Periodontal treatment outcomes during pregnancy and postpartum

Carlos Heitor Cunha Moreira, Patrícia Weidlich, Tiago Fiorini, José Mariano da Rocha, Marta Liliana Musskopf, Cristiano Susin, Rui Vicente Oppermann, Cassiano Kuchenbecker Rösing

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: This study was conducted to compare periodontal therapy outcomes during pregnancy and after delivery. Materials and methods: One hundred nine pregnant women up to the 20th gestational week (GW) were randomized into two groups: the test group (comprehensive periodontal therapy during pregnancy) and the control group (comprehensive periodontal therapy after delivery). Periodontal examinations comprised plaque index (PI), gingival index (GI), periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and gingival crevicular fluid (GCF) volume. After baseline examination, women in the test group received periodontal treatment up to the 24th GW. The final examination was performed at the 26th to the 28th GW. Women in the control group were treated 30 days after delivery and reexamined 30 days after treatment. Results: Periodontal therapy significantly reduced periodontal inflammation in both groups. The mean percentage of sites with BOP was reduced from 49.14 % (±22.49) to 11.10 % (±7.84) and from 45.71 % (±17.86) to 8.07 % (±5.21) in the test and control groups, respectively (p = 0.95). No statistically significant differences were observed between groups concerning PI, GI, PPD, CAL, and GCF. The reduction in mean percentage of sites with BOP stratified for initial PPD ≥4 mm was higher in the control group (p < 0.01), but no differences were seen regarding GCF in these sites. Conclusions: Hormonal changes during pregnancy do not interfere in treatment outcomes in women with widespread gingival inflammation and limited periodontal destruction. The role of these hormonal changes in pregnant women with different disease patterns remains uncertain. Clinical relevance: Periodontal health can be reestablished irrespective of the hormonal challenge that takes place during pregnancy.

Original languageEnglish (US)
Pages (from-to)1635-1641
Number of pages7
JournalClinical oral investigations
Volume19
Issue number7
DOIs
StatePublished - Sep 19 2015

Fingerprint

Postpartum Period
Gingival Crevicular Fluid
Pregnancy
Periodontal Index
Control Groups
Hemorrhage
Pregnant Women
Therapeutics
Inflammation
Pregnancy Outcome
Health

Keywords

  • Clinical trial
  • Periodontal diseases/therapy
  • Postpartum period
  • Pregnancy

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Moreira, C. H. C., Weidlich, P., Fiorini, T., da Rocha, J. M., Musskopf, M. L., Susin, C., ... Rösing, C. K. (2015). Periodontal treatment outcomes during pregnancy and postpartum. Clinical oral investigations, 19(7), 1635-1641. https://doi.org/10.1007/s00784-014-1386-z

Periodontal treatment outcomes during pregnancy and postpartum. / Moreira, Carlos Heitor Cunha; Weidlich, Patrícia; Fiorini, Tiago; da Rocha, José Mariano; Musskopf, Marta Liliana; Susin, Cristiano; Oppermann, Rui Vicente; Rösing, Cassiano Kuchenbecker.

In: Clinical oral investigations, Vol. 19, No. 7, 19.09.2015, p. 1635-1641.

Research output: Contribution to journalArticle

Moreira, CHC, Weidlich, P, Fiorini, T, da Rocha, JM, Musskopf, ML, Susin, C, Oppermann, RV & Rösing, CK 2015, 'Periodontal treatment outcomes during pregnancy and postpartum', Clinical oral investigations, vol. 19, no. 7, pp. 1635-1641. https://doi.org/10.1007/s00784-014-1386-z
Moreira CHC, Weidlich P, Fiorini T, da Rocha JM, Musskopf ML, Susin C et al. Periodontal treatment outcomes during pregnancy and postpartum. Clinical oral investigations. 2015 Sep 19;19(7):1635-1641. https://doi.org/10.1007/s00784-014-1386-z
Moreira, Carlos Heitor Cunha ; Weidlich, Patrícia ; Fiorini, Tiago ; da Rocha, José Mariano ; Musskopf, Marta Liliana ; Susin, Cristiano ; Oppermann, Rui Vicente ; Rösing, Cassiano Kuchenbecker. / Periodontal treatment outcomes during pregnancy and postpartum. In: Clinical oral investigations. 2015 ; Vol. 19, No. 7. pp. 1635-1641.
@article{d4f083a0740a44ed9c672bb872a219da,
title = "Periodontal treatment outcomes during pregnancy and postpartum",
abstract = "Objective: This study was conducted to compare periodontal therapy outcomes during pregnancy and after delivery. Materials and methods: One hundred nine pregnant women up to the 20th gestational week (GW) were randomized into two groups: the test group (comprehensive periodontal therapy during pregnancy) and the control group (comprehensive periodontal therapy after delivery). Periodontal examinations comprised plaque index (PI), gingival index (GI), periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and gingival crevicular fluid (GCF) volume. After baseline examination, women in the test group received periodontal treatment up to the 24th GW. The final examination was performed at the 26th to the 28th GW. Women in the control group were treated 30 days after delivery and reexamined 30 days after treatment. Results: Periodontal therapy significantly reduced periodontal inflammation in both groups. The mean percentage of sites with BOP was reduced from 49.14 {\%} (±22.49) to 11.10 {\%} (±7.84) and from 45.71 {\%} (±17.86) to 8.07 {\%} (±5.21) in the test and control groups, respectively (p = 0.95). No statistically significant differences were observed between groups concerning PI, GI, PPD, CAL, and GCF. The reduction in mean percentage of sites with BOP stratified for initial PPD ≥4 mm was higher in the control group (p < 0.01), but no differences were seen regarding GCF in these sites. Conclusions: Hormonal changes during pregnancy do not interfere in treatment outcomes in women with widespread gingival inflammation and limited periodontal destruction. The role of these hormonal changes in pregnant women with different disease patterns remains uncertain. Clinical relevance: Periodontal health can be reestablished irrespective of the hormonal challenge that takes place during pregnancy.",
keywords = "Clinical trial, Periodontal diseases/therapy, Postpartum period, Pregnancy",
author = "Moreira, {Carlos Heitor Cunha} and Patr{\'i}cia Weidlich and Tiago Fiorini and {da Rocha}, {Jos{\'e} Mariano} and Musskopf, {Marta Liliana} and Cristiano Susin and Oppermann, {Rui Vicente} and R{\"o}sing, {Cassiano Kuchenbecker}",
year = "2015",
month = "9",
day = "19",
doi = "10.1007/s00784-014-1386-z",
language = "English (US)",
volume = "19",
pages = "1635--1641",
journal = "Clinical Oral Investigations",
issn = "1432-6981",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Periodontal treatment outcomes during pregnancy and postpartum

AU - Moreira, Carlos Heitor Cunha

AU - Weidlich, Patrícia

AU - Fiorini, Tiago

AU - da Rocha, José Mariano

AU - Musskopf, Marta Liliana

AU - Susin, Cristiano

AU - Oppermann, Rui Vicente

AU - Rösing, Cassiano Kuchenbecker

PY - 2015/9/19

Y1 - 2015/9/19

N2 - Objective: This study was conducted to compare periodontal therapy outcomes during pregnancy and after delivery. Materials and methods: One hundred nine pregnant women up to the 20th gestational week (GW) were randomized into two groups: the test group (comprehensive periodontal therapy during pregnancy) and the control group (comprehensive periodontal therapy after delivery). Periodontal examinations comprised plaque index (PI), gingival index (GI), periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and gingival crevicular fluid (GCF) volume. After baseline examination, women in the test group received periodontal treatment up to the 24th GW. The final examination was performed at the 26th to the 28th GW. Women in the control group were treated 30 days after delivery and reexamined 30 days after treatment. Results: Periodontal therapy significantly reduced periodontal inflammation in both groups. The mean percentage of sites with BOP was reduced from 49.14 % (±22.49) to 11.10 % (±7.84) and from 45.71 % (±17.86) to 8.07 % (±5.21) in the test and control groups, respectively (p = 0.95). No statistically significant differences were observed between groups concerning PI, GI, PPD, CAL, and GCF. The reduction in mean percentage of sites with BOP stratified for initial PPD ≥4 mm was higher in the control group (p < 0.01), but no differences were seen regarding GCF in these sites. Conclusions: Hormonal changes during pregnancy do not interfere in treatment outcomes in women with widespread gingival inflammation and limited periodontal destruction. The role of these hormonal changes in pregnant women with different disease patterns remains uncertain. Clinical relevance: Periodontal health can be reestablished irrespective of the hormonal challenge that takes place during pregnancy.

AB - Objective: This study was conducted to compare periodontal therapy outcomes during pregnancy and after delivery. Materials and methods: One hundred nine pregnant women up to the 20th gestational week (GW) were randomized into two groups: the test group (comprehensive periodontal therapy during pregnancy) and the control group (comprehensive periodontal therapy after delivery). Periodontal examinations comprised plaque index (PI), gingival index (GI), periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and gingival crevicular fluid (GCF) volume. After baseline examination, women in the test group received periodontal treatment up to the 24th GW. The final examination was performed at the 26th to the 28th GW. Women in the control group were treated 30 days after delivery and reexamined 30 days after treatment. Results: Periodontal therapy significantly reduced periodontal inflammation in both groups. The mean percentage of sites with BOP was reduced from 49.14 % (±22.49) to 11.10 % (±7.84) and from 45.71 % (±17.86) to 8.07 % (±5.21) in the test and control groups, respectively (p = 0.95). No statistically significant differences were observed between groups concerning PI, GI, PPD, CAL, and GCF. The reduction in mean percentage of sites with BOP stratified for initial PPD ≥4 mm was higher in the control group (p < 0.01), but no differences were seen regarding GCF in these sites. Conclusions: Hormonal changes during pregnancy do not interfere in treatment outcomes in women with widespread gingival inflammation and limited periodontal destruction. The role of these hormonal changes in pregnant women with different disease patterns remains uncertain. Clinical relevance: Periodontal health can be reestablished irrespective of the hormonal challenge that takes place during pregnancy.

KW - Clinical trial

KW - Periodontal diseases/therapy

KW - Postpartum period

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84939463599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939463599&partnerID=8YFLogxK

U2 - 10.1007/s00784-014-1386-z

DO - 10.1007/s00784-014-1386-z

M3 - Article

VL - 19

SP - 1635

EP - 1641

JO - Clinical Oral Investigations

JF - Clinical Oral Investigations

SN - 1432-6981

IS - 7

ER -